News

The Phase IIb trial is a multi-center, global, randomized, double-blind, placebo-controlled study in RSV-infected lung transplant patients with a primary endpoint of a reduction in incidence of new

The solution removes a key bottleneck in the current workflow for sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic

CEL-SCI’s rheumatoid arthritis vaccine CEL-2000 was discovered as part of work with the company’s ongoing research and development activities with its LEAPS (Ligand Epitope Antigen Presentation System) technology.

Watson’s 174mg and 348mg strength bupropion hydrobromide tablet products are generic versions of Biovail’s Aplenzin ER, which is indicated for major depressive disorder. Reportedly, Biovail filed suit against

By employing demand flow technology throughout its manufacturing system, Segue provides a standardised process and methodology that drives consistent change management and improvement with a proven roadmap and

The companies said that the agreement includes an upfront fee and potential milestones totaling over $200m as well as product royalties. Lauren Silverman, managing director of Novartis Option

Transcept Pharmaceuticals submitted a revised proposal for the resubmission of the Intermezzo New Drug Application (NDA) to the FDA for evaluation and comment. The FDA stated in the

Under the collaboration, the organisations intend to initially develop and manufacture vaccines for flu, dengue fever and West Nile virus. Phillip Frost, chairman and CEO of Opko, said:

By displaying the current condition of the cerebral tissue directly in the angio suite, syngo Neuro Parenchymal Blood Volume, Interventional Suite (PBV IR) assists in the accurate guidance